Skip to content

Prepaid expenses at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
IQVIA logo
IQVIAIQV
Danaher logo
DanaherDHR
Arrowhead Research logo
Arrowhead ResearchARWR
Bruker logo
BrukerBRKR
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's prepaid expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's prepaid expenses?
Charles River Laboratories (CRL) reported prepaid expenses of $102.15M in Q1 2026.
How has Charles River Laboratories's prepaid expenses changed year-over-year?
Charles River Laboratories's prepaid expenses decreased by 21.4% year-over-year, from $129.99M to $102.15M.
What is the long-term trend for Charles River Laboratories's prepaid expenses?
Over 5 years (2020 to 2025), Charles River Laboratories's prepaid expenses has grown at a -0.1% compound annual growth rate (CAGR), from $96.71M to $96.11M.